Standard Operating Procedure for Regulatory Activity Prioritization During Peak Filing Periods
| Department | Regulatory Affairs |
| SOP No. | RA/2026/611 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 07/04/2026 |
| Effective Date | 07/04/2026 |
| Review Date | 07/04/2028 |
Purpose
This Standard Operating Procedure (SOP) establishes the systematic approach for prioritizing regulatory activities during peak filing periods to ensure timely and compliant submissions. It supports effective resource allocation, risk mitigation, and adherence to regulatory timelines, thereby maintaining compliance with applicable regulatory requirements and internal quality standards.
Scope
This SOP applies to all regulatory activities related to submission planning and execution across all functional areas within Regulatory Affairs, including dossier preparation, review, approvals, and filings. It covers all types of regulatory filing submissions such as new drug applications, variations, renewals, and responses to regulatory queries. Activities outside filing periods or related exclusively to non-regulatory document management are excluded.
Responsibilities
Regulatory Affairs Team members are responsible for identifying submission priorities and preparing filings according to timelines. Regulatory Operations Coordinators manage workflow scheduling and resource allocation. Quality Assurance verifies compliance with filing requirements and reviews prioritization rationale. Regulatory Management oversees implementation and adjustment of prioritization strategies. All personnel involved must document activities accurately and escalate issues as per protocol.
Accountability
The Head of Regulatory Affairs is accountable for the overall implementation, compliance monitoring, periodic effectiveness review, escalation of risks, and ensuring adherence to this SOP. This role is also responsible for approving prioritization plans and securing resources necessary for high-priority regulatory submissions during peak periods.
Procedure
The prioritization of regulatory activities during peak filing periods shall be conducted in a structured manner to optimize resource utilization, ensure compliance, and meet regulatory deadlines.
1. Preparation and Prerequisites: Prior to peak periods, Regulatory Affairs shall forecast expected filings based on regulatory calendars, submission commitments, and stakeholder inputs. A prioritization matrix will be prepared considering factors such as submission deadlines, regulatory impact, resource availability, and compliance risks.
2. Safety and GMP Checks: Although this SOP focuses on priority setting rather than physical safety, adherence to applicable Good Regulatory Practices (GRP) and GMP where relevant to dossier content and compliance checks shall be ensured.
3. Execution Steps:
- Collect and review all planned and anticipated regulatory filing activities for the peak period.
- Assess each activity’s criticality based on regulatory deadlines, business impact, and potential risks.
- Apply the prioritization matrix to assign high, medium, or low priority labels to each filing activity.
- Allocate internal resources, including personnel and technical support, according to priority categories, ensuring high-priority filings receive sufficient attention.
- Develop a detailed filing schedule incorporating milestones, review cycles, and regulatory submission dates aligned with priorities.
- Communicate the prioritization plan and schedules with cross-functional teams to align expectations and resources.
4. In-Process Controls and Verification: Throughout the filing process, monitor status against the prioritization schedule. Address deviations promptly, escalating potential delays or compliance concerns to the Head of Regulatory Affairs.
5. Acceptance Criteria: Regulatory submissions must be completed and filed within assigned priority timeframes without compromising quality or compliance standards.
6. Deviations and Approvals: Any deviations from the prioritization plan require documented justification and approval by the Head of Regulatory Affairs. Corrective actions must be implemented to prevent recurrence.
7. Documentation and Record Retention: Maintain complete records of prioritization decisions, resource assignments, progress reports, deviation logs, and management approvals. All documentation shall be retained according to company policy and regulatory expectations.
8. Closure: Following completion of the peak period, conduct a post-mortem review assessing the effectiveness of the prioritization process. Document lessons learned and update this SOP or related procedures as needed to enhance future filing cycles.
Abbreviations
- GRP: Good Regulatory Practices
- GMP: Good Manufacturing Practice
- QA: Quality Assurance
- RA: Regulatory Affairs
- RFP: Regulatory Filing Plan
Documents
Only documents essential to planning and managing regulatory activity prioritization are included.
- Regulatory Filing Priority Matrix (Annexure-1)
- Regulatory Filing Schedule Template (Annexure-2)
- Regulatory Activity Deviation Log (Annexure-3)
References
- ICH Q10 Pharmaceutical Quality System – for quality management principles.
- FDA’s Guidance on Submitting Regulatory Documents – timelines and requirements.
- Internal Quality Management System Documentation Requirements.
- ISO 9001:2015 – Quality management systems requirements.
- Company Regulatory Compliance Policy and Procedures.
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Regulatory Filing Priority Matrix
Purpose: To provide a structured evaluation tool for prioritizing regulatory filing activities during peak periods based on critical criteria.
| Submission ID | Submission Type | Regulatory Deadline | Business Impact (High/Med/Low) | Compliance Risk | Priority Level | Remarks |
|---|---|---|---|---|---|---|
| SUBM-001 | New Drug Application | 15/05/2026 | High | High | High | Critical launch timeline |
| SUBM-002 | Variation Filing | 30/05/2026 | Medium | Medium | Medium | Post-approval changes |
| SUBM-003 | Renewal Application | 10/06/2026 | Low | Low | Low | Routine renewal |
Annexure-2: Regulatory Filing Schedule Template
Purpose: To document and schedule filing activities aligned with priorities ensuring timely submission.
| Task ID | Submission ID | Task Description | Responsible Person | Start Date | Due Date | Status |
|---|---|---|---|---|---|---|
| TASK-101 | SUBM-001 | Compile dossier sections | Regulatory Affairs Team | 01/04/2026 | 10/04/2026 | In Progress |
| TASK-102 | SUBM-002 | Review and approval of variation | Quality Assurance | 05/04/2026 | 15/04/2026 | Pending |
| TASK-103 | SUBM-003 | Prepare renewal documents | Regulatory Affairs Team | 10/04/2026 | 20/04/2026 | Pending |
Annexure-3: Regulatory Activity Deviation Log
Purpose: To record, justify, and track deviations from the established prioritization plan during peak filing periods.
| Deviation ID | Date | Submission ID | Description of Deviation | Impact | Corrective Action | Approval Status |
|---|---|---|---|---|---|---|
| DEV-001 | 18/05/2026 | SUBM-001 | Delay in dossier compilation due to resource unavailability | Potential delay in filing | Reallocation of personnel and overtime work approved | Approved |
| DEV-002 | 22/05/2026 | SUBM-002 | Incomplete document review cycle | Compliance risk | Additional review and quality checks implemented | Pending |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 07/04/2026 | 1.0 | Initial issue | New SOP creation |